Delivery Order SPE2DB20D2002-SPE2DB25FL62Z
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Losartan Potassium 50 mg tablets (1,000 count) with a ceiling value of $1,061.64. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the contractor. The order is scheduled for ultimate completion by September 15, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Losartan Potassium 50 mg tablets (1,000 count) with a ceiling value of $2,134.71. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by September 8, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,011.75 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of 1,000 tablets of Losartan Potassium 50 mg. This contract represents a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,151.65. This is a firm fixed price delivery order with an ultimate completion date of August 21, 2025. The award was not set-aside and represents a competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Losartan Potassium 25 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,674.46. This award is issued as a firm fixed price delivery order with an ultimate completion date of June 25, 2025, and represents a non-competitive set-aside award. The contract is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units. The contract carries a ceiling value of $19,708.52 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 15, 2025. This award was made on a competitive basis without set-aside designation, with performance to be executed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a Delivery Order contract to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units, with a ceiling value of $1,221.28 and an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for 1,000 tablets of Losartan Potassium 100 mg at a ceiling value of $1,650.11. This is a firm fixed price delivery order with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's ability to meet federal procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. Valued at $1,016.18 with firm fixed pricing, this non-set-aside delivery order is scheduled for completion by August 20, 2025, with performance occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of 1,000 tablets of Losartan Potassium 100 mg, valued at $3,470.22. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Losartan potassium is a generic antihypertensive...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL62ZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of 1,000 tablets of Losartan Potassium 50 mg at a ceiling value of $1,120.32. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and is classified as a child contract under a larger vehicle. This delivery order falls under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle supports the pharmaceutical supply needs of military healthcare systems and other federal medical programs on a global basis. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, supplying an extensive portfolio of medications and medical supplies across multiple therapeutic domains through competitively awarded delivery orders with firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/4/25 |